144 related articles for article (PubMed ID: 34075018)
21. Endothelial CXCR7 regulates breast cancer metastasis.
Stacer AC; Fenner J; Cavnar SP; Xiao A; Zhao S; Chang SL; Salomonnson A; Luker KE; Luker GD
Oncogene; 2016 Mar; 35(13):1716-24. PubMed ID: 26119946
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
23. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
Fumagalli A; Zarca A; Neves M; Caspar B; Hill SJ; Mayor F; Smit MJ; Marin P
Mol Pharmacol; 2019 Dec; 96(6):794-808. PubMed ID: 30837297
[TBL] [Abstract][Full Text] [Related]
24. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
[TBL] [Abstract][Full Text] [Related]
25. Targeting chemokine receptor CXCR7 inhibits glioma cell proliferation and mobility.
Liu Y; Carson-Walter E; Walter KA
Anticancer Res; 2015 Jan; 35(1):53-64. PubMed ID: 25550535
[TBL] [Abstract][Full Text] [Related]
26. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
27. Lymphatic endothelial-cell expressed ACKR3 is dispensable for postnatal lymphangiogenesis and lymphatic drainage function in mice.
Sigmund EC; Baur L; Schineis P; Arasa J; Collado-Diaz V; Vranova M; Stahl RAK; Thelen M; Halin C
PLoS One; 2021; 16(4):e0249068. PubMed ID: 33857173
[TBL] [Abstract][Full Text] [Related]
28. Decreased ACKR3 (CXCR7) function causes oculomotor synkinesis in mice and humans.
Whitman MC; Miyake N; Nguyen EH; Bell JL; Matos Ruiz PM; Chan WM; Di Gioia SA; Mukherjee N; Barry BJ; Bosley TM; Khan AO; Engle EC
Hum Mol Genet; 2019 Sep; 28(18):3113-3125. PubMed ID: 31211835
[TBL] [Abstract][Full Text] [Related]
29. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
30. CXCR7 impact on CXCL12 biology and disease.
Sánchez-Martín L; Sánchez-Mateos P; Cabañas C
Trends Mol Med; 2013 Jan; 19(1):12-22. PubMed ID: 23153575
[TBL] [Abstract][Full Text] [Related]
31. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
[TBL] [Abstract][Full Text] [Related]
32. Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements.
Doijen J; Van Loy T; De Haes W; Landuyt B; Luyten W; Schoofs L; Schols D
PLoS One; 2017; 12(9):e0185354. PubMed ID: 28945785
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization.
Vestal RD; LaJeunesse DR; Taylor EW
Curr Top Med Chem; 2016; 16(13):1427-40. PubMed ID: 26369825
[TBL] [Abstract][Full Text] [Related]
34. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
[TBL] [Abstract][Full Text] [Related]
35. Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239.
Richard-Bildstein S; Aissaoui H; Pothier J; Schäfer G; Gnerre C; Lindenberg E; Lehembre F; Pouzol L; Guerry P
J Med Chem; 2020 Dec; 63(24):15864-15882. PubMed ID: 33314938
[TBL] [Abstract][Full Text] [Related]
36. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells.
Odemis V; Boosmann K; Heinen A; Küry P; Engele J
J Cell Sci; 2010 Apr; 123(Pt 7):1081-8. PubMed ID: 20197403
[TBL] [Abstract][Full Text] [Related]
37. Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
Silwedel C; Speer CP; Haarmann A; Fehrholz M; Claus H; Buttmann M; Glaser K
J Neuroinflammation; 2018 May; 15(1):156. PubMed ID: 29792190
[TBL] [Abstract][Full Text] [Related]
38. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
39. Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface.
Quinn KE; Matson BC; Caron KM
Placenta; 2020 Jun; 95():18-25. PubMed ID: 32452398
[TBL] [Abstract][Full Text] [Related]
40. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines.
Miekus K; Jarocha D; Trzyna E; Majka M
Folia Histochem Cytobiol; 2010 Jan; 48(1):104-11. PubMed ID: 20529825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
